Microhomology-mediated tandem duplication (TD) is a distinct mutational signature in BRCA1-deficient tumors. While several mechanisms have been proposed for its generation, much understanding comes from repeat-based reporters, which may not represent the region of the human genome lacking neighboring repeats. To address this limitation, we developed a repeat-less TD reporter and a PCR-based endogenous site-specific TD assay to examine TDs induced by replication-coupled single-ended DNA double-strand breaks (seDSBs) in Brca1-deficient mouse embryonic stem cells. While TDs induced by seDSBs were detectable in wild-type cells, they were significantly elevated in Brca1-deficient cells, independent of classical non-homologous end joining. Some of these TDs arose from allelic DNA synthesis followed by a shift to microhomology-mediated non-allelic sister chromatid recombination, suggesting increased premature termination of allelic DNA synthesis, a late step of allelic break-induced replication (aBIR), in Brca1-deficient cells. Disrupting RAD51 loading reduced TDs in wild-type cells but not in Brca1-deficient cells, indicating both RAD51-dependent and -independent TD formation. Additionally, RAD54 and BRCA1-BARD1 suppressed TDs in a RAD51-dependent manner, with the effect of BARD1 effect partially mediated through RAD51 interaction. These findings together implicate late steps of aBIR in TD suppression and provide novel insights into the mechanisms underlying BRCA1-linked TD formation in cancer.
Late steps of allelic break-induced replication suppress tandem duplication associated with BRCA1 deficiency.
等位基因断裂诱导复制的后期步骤抑制与 BRCA1 缺陷相关的串联重复
阅读:3
作者:Huang Zhi-Cheng, Feng Yi-Li, Liu Qian, Chen Ruo-Dan, Liu Si-Cheng, Wang Meng, Xie An-Yong
| 期刊: | Nucleic Acids Research | 影响因子: | 13.100 |
| 时间: | 2025 | 起止号: | 2025 Jul 19; 53(14):gkaf729 |
| doi: | 10.1093/nar/gkaf729 | 研究方向: | 其它 |
特别声明
1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。
2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。
3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。
4、投稿及合作请联系:info@biocloudy.com。
